Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries

Vaccine

Volumn 34, Issue 7, 2016, Pages 899-904

  Kristensen, Debra D ^a   Lorenson, Tina ^a,b   Bartholomew, Kate ^a   Villadiego, Shirley ^a  

^a PATH   (United States)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Cold chain; Controlled temperature chain; Thermostable; Vaccine stability

Indexed keywords

ROTAVIRUS VACCINE; VACCINE;

ARTICLE; COLD; CONTROLLED TEMPERATURE CHAIN; DRUG COST; DRUG STABILITY; DRUG STORAGE; FREEZING; HEAT; HIGH TEMPERATURE; HUMAN; PERCEPTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REFRIGERATOR; SEMI STRUCTURED INTERVIEW; THERMOSTABILITY; VACCINE PRODUCTION; BRAZIL; CHINA; ECONOMICS; HEALTH CARE PERSONNEL; INDIA; INTERVIEW; PERU; PHILIPPINES; QUALITY CONTROL; REFRIGERATION; TANZANIA; TRAFFIC AND TRANSPORT;

BRAZIL; CHINA; DRUG STABILITY; DRUG STORAGE; FREEZING; HEALTH PERSONNEL; HOT TEMPERATURE; INDIA; INTERVIEWS AS TOPIC; PERU; PHILIPPINES; QUALITY CONTROL; REFRIGERATION; TANZANIA; TRANSPORTATION; VACCINE POTENCY; VACCINES;

EID: 84957849126     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.01.001     Document Type: Article

References (31)

1. Matthias D.M., Robertson J., Garrison M.M., Newland S., Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007, 25(20):3980-3986.
2. Nelson C., Froes P., Van Dyck A.M., Chavarría J., Boda E., Coca A., et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007, 25(3):433-437.
3. Guichard S., Hymbaugh K., Burkholder B., Diorditsa S., Navarro C., Ahmed S., et al. Vaccine wastage in Bangladesh. Vaccine 2010, 28(3):858-863.
4. Murhekar M., Dutta S., Kapoor A.N., Bitragunta S., Dodum R., Ghosh P., et al. Frequent exposure to suboptimal temperatures in vaccine cold-chain systems in India: results of temperature monitoring in 10 states. Bull World Health Org 2013, 91:906-913.
5. World Health Organization Effective Vaccine Management (EVM) Initiative. Global Data Analysis 2010-2013 2014, Available at: http://www.who.int/immunization/programmes_systems/supply_chain/evm/en/index4.html.
6. Humphreys G. Vaccination: rattling the supply chain. Bull World Health Org 2011, 89:324-325.
7. Kaufmann J.R., Miller R., Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff 2011, 30(6):1113-1121.
8. Zaffran M., Vandelaer J., Kristensen D., Melgaard B., Yadav P., Antwi-Agyei K.O., et al. The imperative for stronger vaccine supply and logistics systems. Vaccine 2013, 31(Suppl 2):B73-B80.
9. Chen D., Kristensen D. Opportunities and challenges of developing thermostable vaccines. Exp Rev Vaccines 2009, 8(5):547-557.
10. World Health Organization Assessing the Programmatic Suitability of Vaccine Candidates for WHO Prequalification 2012, WHO, Geneva, Available at: http://apps.who.int/iris/bitstream/10665/76537/1/WHO_IVB_12.10_eng.pdf.
11. World Health Organization Immunization, Vaccines and Biologicals Newsroom. Revolutionary meningitis vaccine breaks another barrier; first to gain approval to travel outside cold chain 2012, Available at: http://www.who.int/immunization/newsroom/menafrivac_20121114/en/index.html.
12. World Health Organization Immunization, Vaccines and Biologicals. IVB Document Centre. Use of MenAfriVac™ (meningitis A vaccine) in a controlled-temperature chain (CTC) during campaigns 2013, Available at: http://www.who.int/immunization/documents/WHO_IVB_13.04_5_6/en/.
13. Quiroga R., Halkyer P., Gil F., Nelson C., Kristensen D. A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants. Pan Am J Public Health 1998, 4(1):20-25.
14. Sutanto A., Suarnawa I.M., Nelson C.M., Stewart T., Indijati Soewarso T. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Org 1999, 77(2):119-126.
15. Halm A., Yalcouyé I., Kamissoko M., Keïta T., Modjirom N., Zipursky S., et al. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali. Vaccine 2010, 28(19):3467-3472.
16. Zipursky S., Boualam L., Cheikh D.O., Fournier-Caruana J., Hamid D., Janssen M., et al. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad. Vaccine 2011, 29(34):5652-5656.
17. Wang L. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Org 2007, 85(9):688-694.
18. Ateudjieu J., Kenfack B., Nkontchou B.W., Demanou M. Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon. BMC Res Notes 2013, 6(101):1-7.
19. Rogie B., Berhane Y., Bisrat F. Assessment of cold chain status for immunization in central Ethiopia. Ethiop Med J 2013, 51(Suppl 1):21-29.
20. Burstein R., Dansereau E.A., Conner O.R., DeCenso B.M., Delwiche K.P., Gasasira A., et al. Assessing vaccine cold chain storage quality: a cross-sectional study of health facilities in three African countries [meeting abstract]. Lancet 2013, 381(special issue):S25.
21. Kamara L., Lydon P., Bilous J., Vandelaer J., Eggers R., Gacic-Dobo M., et al. Global immunization vision and strategy (GIVS): a mid-term analysis of progress in 50 countries. Health Policy Plan 2013, 28(1):11-19.
22. Juan-Giner A., Domicent C., Langendorf C., Roper M.H., Baoundoh P., Fermon F., et al. A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain. Vaccine 2014, 32(47):6220-6226.
23. Zipursky S., Djingarey M.I.H., Lodjo J.C., Olodo L., Tiendrebeogo S., Ronveaux O. Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled-temperature chain during the mass immunization campaign in Benin. Vaccine 2014, 32(13):1431-1435.
24. Lee B.Y., Cakouros B.E., Assi T.M., Connor D.L., Welling J., Kone S., et al. The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 2012, 30(38):5637-5643.
25. PATH, Working in Tandem, Ltd Summary of stability data for licensed vaccines 2012, http://www.path.org/publications/files/TS_vaccine_stability_table.pdf.
26. World Health Organization The controlled-temperature chain: frequently asked questions 2015, Available at: http://www.who.int/immunization/programmes_systems/supply_chain/resources/Controlled-Temperature-Chain-FAQ.pdf [Accessed 20.08.05].
27. Kartoglu U., Ozgüler N.K., Wolfson L.J., Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Org 2010, 88(8):624-631.
28. World Health Organization Performance, quality and safety (PQS) guidelines 2013, Available at: http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/catdocumentation.aspx?id_cat=18.
29. Braun L.J., Tyagi A., Perkins S., Carpenter J., Sylvester D., Guy M., et al. Development of a freeze-stable formulation for vaccines containing aluminum adjuvants. Vaccine 2009, 27:72-79.
30. Braun L.J., Jezek J., Peterson S., Tyagi A., Perkins S., Sylvester D., et al. Characterization of a thermostable hepatitis B vaccine formulation. Vaccine 2009, 27(34):4609-4614.
31. Kristensen D., Chen D., Cummings R. Vaccine stabilization: research, commercialization and potential impact. Vaccine 2011, 29(41):7122-7124.